Article Text

Download PDFPDF
Case report
Unexpected combination: DiGeorge syndrome and myeloperoxidase deficiency
  1. Simona Abraitytė1,
  2. Elisabeth Kotsi2,
  3. Lisa Anne Devlin3 and
  4. John David Moore Edgar4
  1. 1Lithuanian University of Health Sciences, Kaunas, Lithuania
  2. 2General Hospital of Kalamata, Antikalamos, Greece
  3. 3Regional Immunology Service, Royal Victoria Hospital, Belfast, UK
  4. 4Immunology, St James's Hospital, Dublin, Ireland
  1. Correspondence to Dr Lisa Anne Devlin; lisa.devlin{at}belfasttrust.hscni.net

Abstract

We report a case of a 3-year-old boy who presented with recurrent bacterial and fungal infections and a known diagnosis of partial DiGeorge (22q11.2 deletion) syndrome. The nature and severity of his infections were more than normally expected in partial DiGeorge syndrome with normal T-cell counts and T-cell proliferative response to phytohaemagglutinin. This prompted further investigation of the immune system. An abnormal neutrophil respiratory oxidative burst, but normal protein expression of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system, led to the identification of myeloperoxidase deficiency. DiGeorge syndrome has a heterogeneous clinical phenotype and may not be an isolated diagnosis. It raises awareness of the possibility of two rare diseases occurring in a single patient and emphasises that even when a rare diagnosis is confirmed, if the clinical features remain atypical or unresponsive, then further investigation for additional cofactors is warranted.

  • infections
  • paediatrics (drugs and medicines)
  • genetic screening/counselling
  • immunology
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors SA and EK contributed equally to this paper which included preparation of the manuscript. LAD (corresponding author) and JDME were both involved in preparation of the manuscript, editing and final approval of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.